Vimarsana
Biggest News Aggregation in the World

Page 8 - Analytical Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Analytical Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Analytical Development Today - Breaking & Trending Today

Actym Therapeutics Announces Significant Expansion of Senior Leadership - Vimarsana News

Actym Therapeutics Announces Significant Expansion of Senior Leadership

/PRNewswire/ -- Actym Therapeutics, a privately held biotechnology company developing STACT, a novel therapeutic platform that delivers immunomodulatory...

Actym Therapeutics Announces Significant Expansion of Senior Leadership - Vimarsana News

Actym Therapeutics Announces Significant Expansion of Senior Leadership

/PRNewswire/ -- Actym Therapeutics, a privately held biotechnology company developing STACT, a novel therapeutic platform that delivers immunomodulatory...

Actym Therapeutics Announces Significant Expansion of Senior Leadership - Vimarsana News

Actym Therapeutics Announces Significant Expansion of Senior Leadership

BERKELEY, Calif., May 12, 2022 /PRNewswire/ -- Actym Therapeutics, a privately held biotechnology company developing STACT, a novel therapeutic pl...

Telangana Minister K T Rama Rao inaugrates Ferring Pharma Genome Valley facility - Vimarsana News

Telangana Minister K T Rama Rao inaugrates Ferring Pharma Genome Valley facility

Anindya Ghosh, Managing Director, Ferring Laboratories Private Limited said, " this site in Hyderabad is an integrated facility with R&D and manufacturing capability. The manufacturing facility is...

Atara Biotherapeutics Announces the Completion of the Acquisition of Its Cell Therapy Manufacturing - Vimarsana News

Atara Biotherapeutics Announces the Completion of the Acquisition of Its Cell Therapy Manufacturing

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced FUJIFILM Diosynth Biotechnologies, a su...